Determinants of SARS-CoV-2 waning immunity in allogeneic hematopoietic stem cell transplant recipients

Hematopoietic stem cell transplant (HSCT) recipients are at high-risk for severe COVID-19 and have altered immune responses to vaccination. We sought to evaluate the dynamics of immune response to BNT162b2 mRN...

Source: Journal of Hematology and Oncology - March 18, 2022 Category: Hematology Authors: Mathieu Leclerc, Rabah Redjoul, Anne Le Bouter, Florence Beckerich, Christine Robin, Vincent Parinet, C écile Pautas, Dehbia Menouche, Selwa Bouledroua, Lydia Roy, Ludovic Cabanne, Yakout Nait-Sidenas, Slim Fourati and Sébastien Maury Tags: Rapid communication Source Type: research